Plasma Vasoprotective Eicosanoid Concentrations in Healthy Greyhounds and Non-Greyhound Dogs

Overview

Journal J Vet Intern Med

Specialties General Medicine
Veterinary Medicine

Date 2016 Jan 26

PMID 26806473

Citations 3

Authors

J T Martinez

L K Rogers

C Kellogg

M C Iazbik

C G Couto

B M Pressler

T M Hoepf

M J Radin

Affiliations

Soon will be listed here.

Abstract

Background: Hypertension and albuminuria often coexist in Greyhounds, suggesting generalized vascular dysfunction that could contribute to the development of a variety of diseases in this breed. Eicosanoid metabolites of arachidonic acid (AA) mediate endothelial function, vascular reactivity, and proteinuria in humans and in rodent models.

Hypothesis: The eicosanoid profile of Greyhounds is shifted toward metabolites that promote vascular dysfunction, hypertension, and proteinuria.

Animals: Healthy Greyhounds (n = 20) and non-Greyhound (n = 20) dogs that were consecutively enrolled in a blood donor program.

Methods: Prospective study. Plasma eicosanoid metabolites were assayed by liquid chromatography/electrospray ionization mass spectrometry (LC/ESI/MS) and compared to systolic blood pressure (SP) measurements and urine albumin concentration.

Results: Isomers of hydroxyeicosatetraenoic acid (HETE) were higher in Greyhounds than non-Greyhounds (median, range in pmol/mL: 5(S)HETE 19.82, 8.55-32.95 versus 13.54, 4.33-26.27, P = .033; 8(S)HETE 9.39, 3.28-19.84 versus 5.80, 2.25-17.66, P = .002; 9(S)HETE 9.46, 2.43-13.79 versus 5.82, 1.50-17.16, P = .026; 12(S)HETE 10.17, 3.81-40.06 versus 7.24, 2.9-16.16, P = .022). Dihydroxyeicosatrienoic acid (DHET) isomers also were higher in Greyhounds compared to non-Greyhounds (mean ± SD in pmol/mL: 8,9DHET 5.78 ± 2.13 versus 4.03 ± 1.36, P = .004; 11,12DHET 11.98 ± 2.86 versus 8.90 ± 3.48, P = .004; 14,15DHET 7.23 ± 2.19 versus 5.76 ± 1.87, P = .028). Albuminuria correlated with total DHET (rs = 0.46, P = .003). SP was positively correlated with 11,12EET (rs = 0.42, P = .006) and 20(S)HETE (rs = 0.38, P = .017). SP and 8,9EET were inversely correlated (rs = -0.49, P = .001).

Conclusions And Clinical Importance: Plasma eicosanoid profile in Greyhounds was consistent with activation of metabolic pathways known to promote vascular dysfunction and might contribute to higher blood pressures and albuminuria. Inhibition of these eicosanoid pathways should be evaluated as therapeutic targets in Greyhounds.

Citing Articles

Vector-borne disease and its relationship to hematologic abnormalities and microalbuminuria in retired racing and show-bred greyhounds.

Kidd L, Hamilton H, Stine L, Qurollo B, Breitschwerdt E J Vet Intern Med. 2022; 36(4):1287-1294.

PMID: 35816034 PMC: 9308419. DOI: 10.1111/jvim.16477.

The Renin-Angiotensin-Aldosterone System in Greyhounds and Non-Greyhound Dogs.

Martinez J, Kellogg C, Iazbik M, Couto C, Pressler B, Hoepf T J Vet Intern Med. 2017; 31(4):988-993.

PMID: 28488321 PMC: 5508314. DOI: 10.1111/jvim.14720.

Hyperhomocysteinemia in Greyhounds and its Association with Hypofolatemia and Other Clinicopathologic Variables.

Heilmann R, Grutzner N, Iazbik M, Lopes R, Bridges C, Suchodolski J J Vet Intern Med. 2016; 31(1):109-116.

PMID: 27864850 PMC: 5259649. DOI: 10.1111/jvim.14597.

References

Jacob F, Polzin D, Osborne C, Neaton J, Lekcharoensuk C, Allen T . Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure. J Am Vet Med Assoc. 2003; 222(3):322-9. DOI: 10.2460/javma.2003.222.322. View

Imig J, Zhao X, Zaharis C, Olearczyk J, Pollock D, Newman J . An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension. 2005; 46(4):975-81. PMC: 1444888. DOI: 10.1161/01.HYP.0000176237.74820.75. View

Court M, Hill D, Kind A, Greenblatt D . Propofol hydroxylation by dog liver microsomes: assay development and dog breed differences. Drug Metab Dispos. 1999; 27(11):1293-9. View

Lara-Garcia A, Couto C, Iazbik M, Brooks M . Postoperative bleeding in retired racing greyhounds. J Vet Intern Med. 2008; 22(3):525-33. DOI: 10.1111/j.1939-1676.2008.0088.x. View

Schneider C, Pozzi A . Cyclooxygenases and lipoxygenases in cancer. Cancer Metastasis Rev. 2011; 30(3-4):277-94. PMC: 3798028. DOI: 10.1007/s10555-011-9310-3. View

Currie G, Delles C . Proteinuria and its relation to cardiovascular disease. Int J Nephrol Renovasc Dis. 2014; 7:13-24. PMC: 3873205. DOI: 10.2147/IJNRD.S40522. View

Marino C, Cober R, Iazbik M, Couto C . White-coat effect on systemic blood pressure in retired racing Greyhounds. J Vet Intern Med. 2011; 25(4):861-5. DOI: 10.1111/j.1939-1676.2011.00735.x. View

Hay Kraus B, Greenblatt D, Venkatakrishnan K, Court M . Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences. Xenobiotica. 2000; 30(6):575-88. DOI: 10.1080/004982500406417. View

Schneider H, TRUEX R, KNOWLES J . COMPARATIVE OBSERVATIONS OF THE HEARTS OF MONGREL AND GREYHOUND DOGS. Anat Rec. 1964; 149:173-9. DOI: 10.1002/ar.1091490202. View

10.

Carpenter J, Andelman N, Moore F, King Jr N . Idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Vet Pathol. 1988; 25(6):401-7. DOI: 10.1177/030098588802500601. View

11.

Manhiani M, Quigley J, Knight S, Tasoobshirazi S, Moore T, Brands M . Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. Am J Physiol Renal Physiol. 2009; 297(3):F740-8. PMC: 2739707. DOI: 10.1152/ajprenal.00098.2009. View

12.

Robertson S, Johnston S, Beemsterboer J . Cardiopulmonary, anesthetic, and postanesthetic effects of intravenous infusions of propofol in greyhounds and non-greyhounds. Am J Vet Res. 1992; 53(6):1027-32. View

13.

Surman S, Couto C, DiBartola S, Chew D . Arterial blood pressure, proteinuria, and renal histopathology in clinically healthy retired racing greyhounds. J Vet Intern Med. 2012; 26(6):1320-9. DOI: 10.1111/j.1939-1676.2012.01008.x. View

14.

Powell W, Rokach J . Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. Biochim Biophys Acta. 2014; 1851(4):340-55. PMC: 5710736. DOI: 10.1016/j.bbalip.2014.10.008. View

15.

R Finco D . Association of systemic hypertension with renal injury in dogs with induced renal failure. J Vet Intern Med. 2004; 18(3):289-94. DOI: 10.1892/0891-6640(2004)18<289:aoshwr>2.0.co;2. View

16.

Barbour T, Johnson S, Cohney S, Hughes P . Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012; 27(7):2673-85. PMC: 3398067. DOI: 10.1093/ndt/gfs279. View

17.

de Jong P, Curhan G . Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol. 2006; 17(8):2120-6. DOI: 10.1681/ASN.2006010097. View

18.

Ma Y, Harder D, Clark J, Roman R . Effects of 12-HETE on isolated dog renal arcuate arteries. Am J Physiol. 1991; 261(2 Pt 2):H451-6. DOI: 10.1152/ajpheart.1991.261.2.H451. View

19.

Wehner A, Hartmann K, Hirschberger J . Associations between proteinuria, systemic hypertension and glomerular filtration rate in dogs with renal and non-renal diseases. Vet Rec. 2008; 162(5):141-7. DOI: 10.1136/vr.162.5.141. View

20.

Shishehbor M, Zhang R, Medina H, Brennan M, Brennan D, Ellis S . Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic Biol Med. 2006; 41(11):1678-83. PMC: 1945055. DOI: 10.1016/j.freeradbiomed.2006.09.001. View